It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability. We therefore investigated association between structural variation in a set of 25 ALS genes, and ALS risk and phenotype. As expected, the repeat expansion in the C9orf72 gene was identified as associated with ALS. Two other ALS-associated structural variants were identified: inversion in the VCP gene and insertion in the ERBB4 gene. All three variants were associated both with increased risk of ALS and specific phenotypic patterns of disease expression. More than 70% of people with respiratory onset ALS harboured ERBB4 insertion compared with 25% of the general population, suggesting respiratory onset ALS may be a distinct genetic subtype.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





















1 King’s College London, Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, De Crespigny Park, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
2 King’s College London, Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, De Crespigny Park, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); Institute of Psychiatry, Psychology and Neuroscience, King’s College London, Department of Biostatistics and Health Informatics, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
3 UMC Utrecht Brain Center, Utrecht University, Department of Neurology, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234)
4 Experimental Neurology; VIB Center for Brain & Disease Research, Laboratory of Neurobiology, KU Leuven – University of Leuven, Department of Neurosciences, Leuven, Belgium (GRID:grid.511015.1)
5 University of Sheffield, Sheffield Institute for Translational Neuroscience (SITraN), Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262)
6 Smurfit Institute of Genetics, Trinity College Dublin, Complex Trait Genomics Laboratory, Dublin, Ireland (GRID:grid.8217.c) (ISNI:0000 0004 1936 9705)
7 “Dino Ferrari” Center, Università degli Studi di Milano, Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano and Department of Pathophysiology and Transplantation, Milano, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
8 Koc University, School of Medicine, Translational Medicine Research Center- NDAL, Istanbul, Turkey (GRID:grid.15876.3d) (ISNI:0000000106887552)
9 Mitochondrial pathology Unit, Instituto de Salud Carlos III, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
10 Neuromuscular Diseases Unit/ALS Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland (GRID:grid.511692.8)
11 Health and Life Sciences, Queen’s University Belfast, Faculty of Medicine, Belfast, UK (GRID:grid.4777.3) (ISNI:0000 0004 0374 7521)
12 Institute of Psychiatry, Psychology and Neuroscience, King’s College London, Department of Biostatistics and Health Informatics, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); University College London, Institute of Health Informatics, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
13 Centre SLA, CHRU de Tours, Tours, France (GRID:grid.411167.4) (ISNI:0000 0004 1765 1600)
14 ALS Centre, University of Torino, Rita Levi Montalcini, Department of Neuroscience, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580); Azienda Ospedaliera Citta della Salute e della Scienza, Torino, Italy (GRID:grid.432329.d) (ISNI:0000 0004 1789 4477)
15 Centre SLA, CHRU de Tours, Tours, France (GRID:grid.411167.4) (ISNI:0000 0004 1765 1600); Federation des Centres SLA Tours and Limoges, LITORALS, Tours, France (GRID:grid.411167.4)
16 University of Lisbon, Physiology Institute, Faculty of Medicine, Instituto de Medicina Molecular, Lisbon, Portugal (GRID:grid.9983.b) (ISNI:0000 0001 2181 4263)
17 Hadassah University Hospital, Jerusalem, Israel (GRID:grid.17788.31) (ISNI:0000 0001 2221 2926)
18 Neurology Department, Hospital Universitari de Bellvitge, Barcelona, Spain (GRID:grid.411129.e) (ISNI:0000 0000 8836 0780)
19 Hospital San Rafael, Madrid, Spain (GRID:grid.411129.e)
20 University of Massachusetts Medical School, Department of Neurology, Worcester, USA (GRID:grid.168645.8) (ISNI:0000 0001 0742 0364)
21 Emory University, Department of Neurology, Center for Neurodegenerative Diseases, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
22 King’s College London, Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, De Crespigny Park, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); King’s College Hospital, Denmark Hill, London, UK (GRID:grid.46699.34) (ISNI:0000 0004 0391 9020)
23 Trinity College Dublin, Trinity Biomedical Sciences Institute, Academic Unit of Neurology, Dublin, Republic of Ireland (GRID:grid.8217.c) (ISNI:0000 0004 1936 9705); Beaumont Hospital, Department of Neurology, Dublin, Republic of Ireland (GRID:grid.414315.6) (ISNI:0000 0004 0617 6058)
24 Experimental Neurology; VIB Center for Brain & Disease Research, Laboratory of Neurobiology, KU Leuven – University of Leuven, Department of Neurosciences, Leuven, Belgium (GRID:grid.511015.1); University Hospitals Leuven, Neurology Department, Leuven, Belgium (GRID:grid.410569.f) (ISNI:0000 0004 0626 3338)